Adults with dyslipidemia and evidence of mild systemic inflammation ( high-sensitivity C-reactive protein [ hs-CRP ] between 2 and 5mg/L ) were randomly allocated to receive either 220.5 mg of cis-palmitoleic acid ( n = 30 ) or an identical capsule with placebo ( 1000mg of medium chain triglycerides , n = 30 ) once per day for 30days .